Condition: Surgery, Cardiac · Tranxemic Acid · Activated Clotting Time · Sponsor: Taichung Veterans General Hospital
The goal of this clinical trial is to the dose effect of tranexamic acid and the level of ACT on bleeding in adult cardiac surgery. The main questions it aims to answer are: 1. Does higher dose of tranexamic acid reduce the amount of bleeding and blood transfusion? 2. Does lower ACT level during cardiac surgery reduce the amount of bleeding and blood transfusion? Participants will divided into four groups which have different tranexamic acid dose and ACT level during cardiac surgery to see if there is any different in the amount of bleeding and blood transfusion.
This description comes directly from the study's public registry record.
Yung-Szu Wu, MD · 0423592525 · adconvert98@gmail.com
Yi-Ting Chang, MD · 04-23592525 · alisonytchang@gmail.com
Always discuss trial participation with your own doctor first.
| Taichung Veterans General Hospital | Taichung, Taiwan | Recruiting |
| Taichung Veterans General hospital | Taichung, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06109155